1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Type 2 diabetes exacerbates changes in blood pressure-independent arterial stiffness : cross-sectional and longitudinal evidence from the SUMMIT study
(
- Contribution to journal › Article
- 2022
-
Mark
Plasma prostasin : a novel risk marker for incidence of diabetes and cancer mortality
(
- Contribution to journal › Article
-
Mark
Proteomic Profiles of Body Mass Index and Waist-to-Hip Ratio and Their Role in Incidence of Diabetes
(
- Contribution to journal › Article
- 2021
-
Mark
Methodological considerations for identifying multiple plasma proteins associated with all-cause mortality in a population-based prospective cohort
(
- Contribution to journal › Article
-
Mark
Elevated circulating follistatin associates with an increased risk of type 2 diabetes
(
- Contribution to journal › Article
-
Mark
The Malmö Offspring Study (MOS) : design, methods and first results
(
- Contribution to journal › Article
- 2020
-
Mark
Circulating protein biomarkers predict incident hypertensive heart failure independently of N-terminal pro-B-type natriuretic peptide levels
(
- Contribution to journal › Article
-
Mark
Identification of Inflammatory and Disease-Associated Plasma Proteins that Associate with Intake of Added Sugar and Sugar-Sweetened Beverages and Their Role in Type 2 Diabetes Risk
(
- Contribution to journal › Article
-
Mark
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
(
- Contribution to journal › Article
- 2019
-
Mark
Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes : A nested, case–control study
(
- Contribution to journal › Article